Barbara Silberberg Cargill

Barbara Silberberg Cargill is a seasoned professional with extensive experience in both technology and psychology. As a Co-Founder at Copptech™ Antimicrobial Technology since October 2018, Barbara has played a pivotal role in shaping the innovation and marketing strategy, leading the Series B funding round, and establishing the UK headquarters. Prior to this, Barbara served in various psychological roles, including clinical psychologist positions at Red de Salud UC CHRISTUS and in private practice, providing psychodiagnosis and psychotherapy for children. Additionally, Barbara contributed to curriculum development for mental health promotion at the Ministerio de Educación Chile. Educational background includes degrees in Clinical Psychology with a focus on child and adolescent psychology from Pontificia Universidad Católica de Chile, along with further specialization in mental health and psychotherapy.